Advertisement

Picture EBD Group ChinaBio Partnerting Forum 2021 651x80
All > Germany >

Deals > Western Germany

Find below deals from the Western German Federal States of Hessen, Nordrhein-Westfalen, Rheinland-Pfalz and Saarland. Listed are news deals for this region as well as from organisations located there.

Total search results: 558 | Ordered by Date (descending)
1 2 3 4 5 6  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
AgomAb Therapeutics–Boehringer: investment, 202103 financing round Series B totalling $74m incl existing + co-investor BIVF 2021-03-10
BellaSeno–Fraunhofer: implant production technology, 202103– collab developm automated resorbable implant production + QC with Fraunhofer IPT 2021-03-10
ActiTrexx–SEVERAL: investment, 202103 financing round Series A €3.5m led by LBBW Venture Capital GmbH 2021-03-02
Kairos GmbH–Iqvia: investment, 202103 acquisition of Kairos GmbH by Iqvia 2021-03-01
InfanDx–Akampion: public relations, 202102 service existent by Akampion 2021-02-04
Carisma Therapeutics–Cevec: cell line technology, 202102– license €na for use of CAP technology to produce adenovirus vectors for cancer cell therapy 2021-02-02
GeneQuine–High-Tech Gründerfonds: investment, 202101 financing round Series A totalling €5.4m incl existing + co-investor HTGF 2021-01-26
i3 Membrane–High-Tech Gründerfonds: investment, 202101 financing round totalling 7-figure € sum inkl existing investor HTGF 2021-01-25
i3 Membrane–SEVERAL: investment, 202101 financing round 7-figure € sum from HTGF + three private investors 2021-01-25
Relief Therapeutics–MC Services: public relations, 202101 service existent by MC Services 2021-01-20
LignoPure–High-Tech Gründerfonds: investment, 202101 seed financing round totalling €2.2m incl investor HTGF 2021-01-18
Biogen–Cevec: cell line technology, 202101– license €na to Elevecta technology for manufacutring of AAV vectors for gene therapies 2021-01-08
AmpTec–Merck (DE): investment, 202101 acquisition €na of AmpTec GmbH bei Merck 2021-01-07
Sterna Biologicals–SEVERAL: investment, 202101 financing round Series A 2nd closing €10m bringing total Series A to €22m 2021-01-07
Biosun Biochemicals–BRAIN: investment, 202101 acquisition 100% €na by BRAIN AG 2021-01-01
MYR GmbH–Gilead Sciences: investment, 202012 acquisition €1.15b in cash + €300m milestones of MYR GmbH by Gilead Sciences Inc 2020-12-10
NBE Therapeutics–Boehringer: investment, 202012– acquisition up to €1.18b by Boehringer 2020-12-10
Resolve Biosciences–Alafi Capital: investment, 202012 financing round Series A totalling $24m incl co-investor Alafi Capital 2020-12-10
Resolve Biosciences–Bioscribe: public relations, 202012 service existent by Bioscribe 2020-12-10
Resolve Biosciences–High-Tech Gründerfonds: investment, 202012 financing round Series A totalling $24m incl co-investor HTGF 2020-12-10
Resolve Biosciences–MasterMind Advisory Services: investment, 202012 financing round Series A totalling $24m incl co-lead investor MasterMind 2020-12-10
Resolve Biosciences–PERSON: investment, 202012 financing round Series A totalling $24m incl co-investor John Shoffner 2020-12-10
Resolve Biosciences–PS Capital Management: investment, 202012 financing round Series A totalling $24m incl co-lead investor PS Capital 2020-12-10
Resolve Biosciences–SEVERAL: investment, 202012 financing round Series A $24m co-led by PS Capital Management + MasterMind Advisory Services 2020-12-10
Boehringer–Proxygen: molecular glue degraders, 202012– collab + license agreem developm in combi with PROTACs against oncogenic targets 2020-12-07
BioNTech–InstaDeep: AI-based drug discovery, 2019– collab initiated in 2019 2020-11-25
BioNTech–InstaDeep: AI-based drug discovery, 202011– strategic collab incl joined AI Innovation Lab to develop immunotherapies 2020-11-25
Emergence Therapeutics–High-Tech Gründerfonds: investment, 202011 follow-on seed financing round incl lead investor HTGF 2020-11-25
Emergence Therapeutics–SEVERAL: investment, 202011 follow-on seed financing round led by HTGF 2020-11-25
m2p-labs–Danaher: investment, 202011 acquisition of m2p-biolabs by Beckman Coulter Life Sciences 2020-11-12
Catalym–Germany (govt): investment, 202011 financing round Series B totalling €50m incl co-investor Coparion 2020-11-10
Roche–Cevec: cell line technology, 202011– license €na to Elevecta technology for manufacutring of AAV vectors for gene therapies 2020-11-10
Vera Therapeutics–Merck (DE): investment, 202011 Merck reveices 10% equity in Vera Tx as part of license deal for atacicept 2020-11-09
Polaris Science (SG)–Nynomic: plant phenotyping, 202011– distribution in Singapore + Malaysia of LemnaTec solutions for phenotyping + seed testing 2020-11-01
MD Biosciences–MLM Medical Labs: investment, 202010 acquisition of MD Biosciences Inc by MLM Medical Labs 2020-10-26
Topas Therapeutics–Boehringer: investment, 202010 financing round Series B totalling €22m incl existing + co-investor BIVF 2020-10-19
Novartis–Merck (DE): Nanobodies, 202010– license €50m upfront + €400m milestones to M6495 anti-ADAMTS5 Nanobody for osteoarthritis 2020-10-06
Heartbeat Medical–High-Tech Gründerfonds: investment, 202010 financing round Series A totalling €5m incl existing + co-investor HTGF 2020-10-05
Prolytic–Kymos: investment, 202009 strategic merger of Polytic GmbH + Kymos SL 2020-09-28
Libra Therapeutics–Boehringer: investment, 202009 financing round Series A totalling $29m incl co-lead investor BIVF 2020-09-23
Jennewein Biotechnologie–Chr. Hansen: investment, 202009– acquisition €310m on debt-free basis ANNOUNCED 2020-09-22
Novartis–BioNTech: investment, 202009– acquisition of Novartis GMP Biologics Manufacturing Site in Marburg by BioNTech 2020-09-17
Boehringer–Click Therapeutics: digital therapeutics, 202009– collab ufpront+milestones >$500m + royalties ww dev+marketing CT-155 for schizophrenia 2020-09-11
Imcyse–MC Services: public relations, 202009 service existent by MC Services 2020-09-07
Boehringer–BiomX: biomarker discovery, 202009– collab discovery of microbiome-based biomarkers for IBD using XMarker platform 2020-09-02
Helmholtz–Bruker: NMR spectrometer, 202009c supply 1.2 GHz NMR spectrometer with 28 Tesla to FZ Jülich 2020-09-01
Semalytix–btov Partners: investment, 202008 financing round Series A totalling €4.3m incl co-lead investor btov 2020-08-31
Semalytix–Fly Ventures: investment, 202008 financing round Series A totalling €4.3m incl existing sedd + co-lead investor Fly Ventures 2020-08-31
Semalytix–SEVERAL: investment, 202008 financing round Series A €4.3m co-led by btov + Fly Ventures 2020-08-31
Aignostics–Boehringer: investment, 202008 seed financing round totalling €5m incl lead investor BIVF 2020-08-28
Aignostics–Hessen (govt): investment, 202008 seed financing round totalling €5m incl co-investor Future Capital 2020-08-28
Aignostics–High-Tech Gründerfonds: investment, 202008 seed financing round totalling €5m incl co-investor HTGF 2020-08-28
Scienion–Cellink: investment, 202008– acquisition €80m on cash/debt-free basis with €40m in shares + €40m in shares 2020-08-19
Atriva Therapeutics–High-Tech Gründerfonds: credit, 202008– convertible loan financing round totalling €8.6m incl existing + co-lead investor HTGF 2020-08-11
T-Knife–Boehringer: investment, 202008 financing round Series A totalling €66m incl existing + co-investor BIVF 2020-08-06
T3 Pharmaceuticals–Boehringer: investment, 202007 3rd financing round totalling CHF25m incl existing investor BIVF 2020-07-22
Quantro Therapeutics–Boehringer: investment, 202007 seed financing round from BIVF + Evotec acquiring equal minority stakes 2020-07-21
Tubulis–Germany (govt): investment, 202007 financing round Series A totalling €10.7m incl co-investor Coparion 2020-07-21
Tubulis–High-Tech Gründerfonds: investment, 202007 financing round Series A totalling €10.7m incl co-lead investor HTGF 2020-07-21
CureVac–Germany (govt): investment, 202007 financing round Series B totalling €560m incl €300m from KfW approx 19% shareholding 2020-07-17
CirQuest Labs–MLM Medical Labs: investment, 202007 acquisition of CirQuest Labs by MLM Medical Labs 2020-07-08
Resolution Spectra Systems–Merck (DE): investment, 202007 acquisition €na of Resolution Spectra Systems by Merck 2020-07-01
Univ Bochum–Max Planck: antibiotics research, 202006– collab establishment CESAR Center for Antibiotics Research at Univ Bochum with LDC 2020-06-18
Univ Bochum–North Rhine-Westphalia (govt): grant, 202006– grant €4m from NRW + EFRO for establishment CESAR Center for Antibiotics Research with LDC 2020-06-18
DiogenX–Boehringer: investment, 202006 seed financing round totalling €4.5m incl investor BIVF 2020-06-16
eTheRNA–Boehringer: investment, 202006 financing round Series B totalling €34m incl existing investor BIVF 2020-06-16
Qurient–Max Planck: proteasome inhibitors, 2012006– collab develop + license + founding of joint venture QLi5 Therapeutics GmbH 2020-06-16
10x Genomics–Merck (DE): CRISPR technology, 202006 collab launch integrated solution for CRISPR research 2020-06-10
Royalty Pharma–AiCuris: letermovir, 202006 acquisition of partial royalty interest on letermovir for one-time payment of $220m by Royalty Pharma 2020-06-09
BRAIN–SEVERAL: investment, 202006 private placenment €14.94m with 1.8m new shares at €8.3/share 2020-06-03
AdvanceCor–Germany (govt): investment, 202006 financing round totalling €3.9m incl existing + co-investor KfW Bank 2020-06-02
Kumovis–High-Tech Gründerfonds: investment, 202005 financing round Series A totalling €3.6m incl existing + co-investor HTGF 2020-05-27
Kumovis–Renolit: investment, 202005 financing round Series A totalling €3.6m incl new + co-lead investor Renolit SE 2020-05-27
Sterna Biologicals–MC Services: public relations, 202005 service existent by MC Services 2020-05-26
Sterna Biologicals–SEVERAL: investment, 202005 financing round Series A first closing €12m with existing + new investors 2020-05-26
Pluristem–Dentons: legal services, 202005 supply service Dentons is adivsor with regard to €50m EIB loan financing 2020-05-05
Kurma–North Rhine-Westphalia (govt): investment, 202004 final closing of Kurma Biofund III totalling €160m incl investor NRW.BANK 2020-04-29
Centogene–Ubirch: blockchain technology, 202004 collab announcing secure blockchain solution for storing SARS-CoV-2 test results 2020-04-17
Evox Therapeutics–Cevec: cell line technology, 202004– license €na for use of CAP technology to produce exosome therapeutics as part of ongoing collab 2020-04-16
Rgenta Therapeutics–Boehringer: investment, 202004 seed financing round totalling $20m incl co-lead investor BIVF 2020-04-02
BioNTech–Pfizer: investment, 202003 equitiy investment $113m by Pfizer in connection with COVID-19 vaccine collaboration 2020-03-17
Pfizer–BioNTech: mRNA-based vaccines, 202003– collab $72m upfront + $563m milestones developm COVID-19 vaccine 2020-03-17
BioNTech–Fosun: investment, 202003 equity investment €44m for 1.58m ordinary shares by Fosun Pharma as part of COVID-19 vaccine collab 2020-03-16
Fosun–BioNTech: mRNA-based vaccines, 202003– collab up to €120m + profit sharing development of COVID-19 vaccine in China with Fosun Pharma 2020-03-16
iAtros–High-Tech Gründerfonds: investment, 202003 seed financing round totalling €2m incl investor HTGF 2020-03-09
Ubirch–SEVERAL: investment, 202003 third financing round seven-digit € amount led by hubraum Deutsche Telekom + NRW.BANK 2020-03-06
Boehringer–Trutino Biosciences: cancer immunotherapy, 202002– collab research + ww excl license to develop up to 3 candidates using ODC technology 2020-02-27
Scipio Bioscience–High-Tech Gründerfonds: investment, 202002 financing round Series A totalling €6m incl existing + co-investor HTGF 2020-02-25
Boehringer–Carebox Healthcare Solutions: clinical research s/w, 202002– use of MyStudyWindow SaaS for global patient recruitment 2020-02-18
Univ Kyoto–Miltenyi Biotec: cell sorting system, 202001 supply existent MACS GMP Tyto Cartrige + MACSquant Tyto Cell Sorter to CiRO as early customer 2020-01-30
HepaRegenix–Boehringer: investment, 202001 financing round Series B totalling €11m incl existing investor BIVF 2020-01-21
HepaRegenix–Germany (govt): investment, 202001 financing round Series B totalling €11m incl existing investor Coparion 2020-01-21
HepaRegenix–High-Tech Gründerfonds: investment, 202001 financing round Series B totalling €11m incl existing investor HTGF 2020-01-21
BioNTech–Covington & Burling: legal services, 202001 supply service legal counsel with regard to merger acquisition of Neon Therapeutics 2020-01-16
Neon Therapeutics–BioNTech: investment, 202001–202005 acquisition merger $67m by BioNTech in all-stock transaction with 0.063 ADSs/share = $2.18/share 2020-01-16
Biograil–High-Tech Gründerfonds: investment, 202001 seed financing round totalling €3m (potentially up to €5m) incl lead investor HTGF 2020-01-15
Amgen–Qiagen: molecular companion diagnostics, 202002– collab developm KRAS G12C CDx for AMG 510 in NSCLC 2020-01-13
NBE Therapeutics–Boehringer: investment, 202001 financing round Series C totalling $22m incl existing + co-lead investor BIVF 2020-01-10
Bayer–Evotec: drug discovery services, 201001–202412 collab expansion women’s health €16.5m upfront + research cost + milestones >€330m drugs for PCOS 2020-01-09
Eyevensys–Boehringer: investment, 202001 financing round Series B totalling $30m incl existing + lead investor Boehringer Ingelheim Venture Fund 2020-01-08
1 2 3 4 5 6  next pagenext page



Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [iito] No Content Marketing 650x80px

» top